Mesoporous Silica Nanoparticles for Bio-Applications

Violeta-Carolina Niculescu
DOI: https://doi.org/10.3389/fmats.2020.00036
2020-02-19
Frontiers in Materials
Abstract:Mesoporous materials with high specific surface, pores volume and unique pore size were recently intensively studied as bio-materials, such as carriers for controlled bio-active principles delivery. Mesoporous silica materials exhibit greater capacity for drugs loading and insure a controlled bio-active compound release if they are functionalized, in comparison with amorphous colloidal silica. Mesoporous silica nanomaterials have lately earned increasing interest also due to their substantial capability to be used in tumors treatment and imaging. Recently, functionalized mesoporous silica materials known a rapid development in imagistic and curative applications. This review summarizes the recent advancement in the obtaining and biological properties of mesoporous silica nanomaterials, emphasizing the synthesis methods and drug delivery application. Commonly used synthetic strategies are discussed, followed by a systematic review of applicability in optical and MRI imaging.
materials science, multidisciplinary
What problem does this paper attempt to address?
The problems that this paper attempts to solve are: How to use mesoporous silica nanoparticles (MSN) as efficient drug carriers in biological applications, especially for cancer treatment and imaging. Specifically, the research aims to explore the following points: 1. **Improve drug - loading capacity**: By optimizing the synthesis methods and functionalization strategies of MSN, increase the drug loading amount and ensure the controllable release of drugs in the target tissues. 2. **Achieve targeted delivery**: Through surface modification or the introduction of targeting ligands, enable MSN to specifically recognize and bind to diseased cells, thereby reducing the impact on healthy cells. 3. **Enhance biocompatibility and safety**: Evaluate the biodistribution, metabolic pathways and potential toxicity of MSN to ensure its safety when used in vivo. 4. **Multifunctional integration**: Develop MSN with dual diagnostic and therapeutic functions, for example, embed fluorescent molecules or magnetic nanoparticles into it, so as to facilitate real - time monitoring of the drug delivery process and efficacy evaluation. 5. **Feasibility of industrial production**: Explore the technical paths for large - scale preparation of high - quality and stable - performance MSN, laying the foundation for clinical transformation. In summary, this review article focuses on the research progress in recent years on the application of mesoporous silica nanoparticles in the biomedical field, with special emphasis on their potential as drug delivery systems and the challenges they face. The article also discusses the influence of different synthesis methods on the structural characteristics of MSN, and summarizes the current knowledge about their biocompatibility, toxicological characteristics, etc., providing a reference direction for future research.